First, in terms of promoting tumorigenesis, METTL1 knockdown reduces downstream signaling activity by reducing mRNA translation in the EGF/EGFR and VEGFA/VEGFR1 signaling pathways, leading to inhibition of HCC proliferation and metastasis. This evidence concerns the gene EGFR and hepatocellular carcinoma.